Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.25ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.25ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DB.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DB.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DB.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.6.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DV.6.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DV.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DV.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DV.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used